<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE326nnn/GSE326229/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE326229</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Transcriptomic effects of intermittent parathyroid hormone treatment on Sox9-lineage osteoprogenitors</name><description>We employed 10X Genomics single cell RNA-sequencing to study the bone anabolic effects of intermittent parathyroid hormone treatment (iPTH) on growth-associated progenitors. These osteoblast progenitors, marked by the expression of the transcription factor SRY-box transcription factor 9 (Sox9), reside in the growth plate and perichondrium that respond to iPTH in early postnatal mice. Whether these cells respond in adult mice is unknown. Using lineage tracing approach with Sox9-CreERT2 crossed with Ai9 tdTomato reporter mice, we traced Sox9-expressing cells and their descendants following 10 days of vehicle or iPTH treatment. This study represents a single cell atlas of Sox9-lineage cells following 10 days of iPTH treatment.</description><dates><publication>2026/09/20</publication></dates><accession>GSE326229</accession><cross_references><GSM>GSM9625583</GSM><GSM>GSM9625582</GSM><GSM>GSM9625581</GSM><GSM>GSM9625580</GSM><GSM>GSM9625587</GSM><GSM>GSM9625576</GSM><GSM>GSM9625586</GSM><GSM>GSM9625575</GSM><GSM>GSM9625585</GSM><GSM>GSM9625584</GSM><GSM>GSM9625579</GSM><GSM>GSM9625578</GSM><GSM>GSM9625588</GSM><GSM>GSM9625577</GSM><GPL>30172</GPL><GSE>326229</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>